A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes

Erstveröffentlichung
2004Authors
Stadler, M
Germing, U
Kliche, KO
Josten, KM
Kuse, R
Wissenschaftlicher Artikel
Published in
Leukemia ; 18 (2004), 3. - S. 460-465. - ISSN 0887-6924
Link to publication
https://dx.doi.org/10.1038/sj.leu.2403239Institutions
UKU. Klinik für Innere Medizin IIISubject headings
[Free subject headings]: myelodysplastic syndromes | immune modulation | antithymocyte globulin | antilymphocyte globulin | aplastic-anemia | bone-marrow | immunosuppressive therapy | classification | cyclosporine | prognosis | cells | atg[DDC subject group]: DDC 610 / Medicine & health